Skip to content
GLP1-US
Prices checked Wegovy pill $149 Wegovy pen $349 Zepbound $299–449 Foundayo from $149 Ozempic $349 Medicare Bridge $50 Compounded sema $175 All prices →

Label and NovoCare price checked Oct 2026

Wegovy HD: What the Wegovy 7.2 mg Dose Does and Costs

Wegovy HD is a 7.2 mg weekly Wegovy shot for adults already on 2.4 mg. It averaged 18.8% to 20.7% weight loss in the STEP UP trial and costs $399/mo self-pay.

  • FDA-approved Mar 19, 2026
  • Only after 4+ weeks on 2.4 mg
  • $399/mo self-pay
  • Adults only

We may earn a commission when you click links to providers, and partner relationships can affect which providers we feature and their order. Advertiser Disclosure

By GLP1-US Editorial TeamUpdated
★ Editor's Choice
Chia Health logo

Chia Health

Our #1 pick for GLP-1 weight loss online

  • One monthly price: clinician, medication and free shipping included
  • Semaglutide or tirzepatide, as a weekly injection or a daily tablet
  • No insurance needed; HSA/FSA and Klarna accepted

Compounded medications, not FDA-approved. Prices checked Nov 17, 2026. Advertiser Disclosure

$212.89 first month, then $349/mo

6-month plan: $249/mo, paid upfront ($1,396.89 for the first 6 months). Microdose: $109.19 first month, then $179/mo.

Get Started Read our Chia Health review

01 The basics

What Is Wegovy HD?

Wegovy HD is the Wegovy high dose: the same semaglutide as every Wegovy and Ozempic product, given at 7.2 mg once a week instead of the usual 2.4 mg top dose.

Same drug, higher dose.

Semaglutide 7.2 mg, three times the standard 2.4 mg maintenance dose. It is not a new molecule, so the boxed warning, the contraindications and the drug interactions are the same as for regular Wegovy.

Its own pen.

A single-dose pen labeled Wegovy HD 7.2 mg/0.75 mL, sold in cartons of 4 pens (one month). You inject once a week, on the same day each week, like the other Wegovy pens.

Narrow use.

Approved for weight reduction and long-term maintenance in adults. It is not established under 18. For heart-risk reduction and for MASH, the label keeps the maintenance dose at 1.7 or 2.4 mg.

The FDA approved Wegovy HD on March 19, 2026, the first GLP-1 approval under the Commissioner's National Priority Voucher pilot. It belongs to the semaglutide family; compare all Wegovy forms, including the daily pill.

02 Eligibility

Who Can Take Wegovy 7.2 mg?

  • YesAdult with obesity, or overweight with a weight-related condition (check your BMI).
  • YesAlready on Wegovy 2.4 mg weekly and tolerating it for at least 4 weeks.
  • YesYour prescriber judges that more weight reduction is clinically indicated.
  • NoNew to Wegovy. Everyone starts at 0.25 mg; 7.2 mg is never a starting dose.
  • NoUnder 18, or using Wegovy only for heart-risk reduction or MASH.
Getting there takes at least 20 weeks. The label escalates 0.25, 0.5, 1 and 1.7 mg for 4 weeks each, then 2.4 mg from week 17. Only after at least 4 weeks on 2.4 mg can the dose go to 7.2 mg, so week 21 is the earliest step-up. If a dose is hard to tolerate, the label lets your prescriber delay the next step by 4 weeks. Your prescriber sets your dose; the full schedule is on Wegovy dosage.

03 Results

Wegovy HD Results: STEP UP Trial

STEP UP enrolled 1,407 adults with obesity and without diabetes and ran 72 weeks. People were randomized 5:1:1 to 7.2 mg, 2.4 mg or placebo, so the trial compares the two Wegovy doses directly.

Average weight loss at 72 weeks, all randomized adults (label, Study 8)

Wegovy HD 7.2 mg 18.8%
Wegovy 2.4 mg 15.5%
Placebo 3.9%

FDA label section 14.2, intent-to-treat (everyone randomized, whether or not they kept taking the drug). 7.2 mg beat 2.4 mg by 3.3 points. Novo Nordisk's efficacy estimand, which assumes everyone stayed on treatment, is 20.7%.

Lost 20% or more

45.5%

vs 32.3% on 2.4 mg and 2.8% on placebo

Lost 25% or more

31.2%

Novo efficacy estimand, about 1 in 3

With type 2 diabetes

13.2%

vs 10.4% on 2.4 mg (STEP UP T2D, n=512)

Lost 15% or more

63.8%

vs 52.3% on 2.4 mg

Two numbers float around for the same trial, which is why you will see both 18.8% and 20.7% quoted. The lower one counts everyone; the higher one estimates the effect for people who took the drug as planned. In STEP UP T2D the same two methods give 13.2% and 14.1%. In a post hoc analysis, 23 of 26 participants with liver fat above 5% (88.5%) reached normal levels, with the 7.2 mg and 2.4 mg groups pooled and no placebo comparison; details in the liver-fat report.

04 Price

Wegovy HD Cost

NovoCare Pharmacy sells Wegovy HD for $399 a month self-pay, $50 more than the lower doses. With insurance or Medicare the out-of-pocket number changes a lot, so check each row before you pick a route.

How you payMonthly cost (as of Oct 2026)
NovoCare self-pay, 7.2 mg HD
Home delivery or participating pharmacies; 1 month = 4 pens
$399
NovoCare self-pay, 0.25 to 2.4 mg
$199 for the first 2 fills at 0.25/0.5 mg, new patients, through Dec 31, 2026
$349
Commercial plan that covers Wegovy
Savings card, maximum savings $100/mo, not for government insurance
As little as $25
Medicare GLP-1 Bridge
CMS lists the Wegovy HD pen (NDC 0169-4572-14); BMI and condition criteria apply; Jul 1, 2026 to Dec 31, 2027
$50
Ro
Ro Body membership $39 first month, then $74 to $149/mo depending on plan length
$399 + membership
Hers
Lists "high dose available" for the Wegovy pen; HD price not published
Ask Hers

Prices as of Oct 2026, may change. NovoCare shows the same list price, $1,349.02 per package, for the Wegovy HD pen as for the other pens; Novo Nordisk cuts the Wegovy list price to $675 a month on Jan 1, 2027. More detail on Wegovy cost and GLP-1 cost with insurance.

05 Tolerability

Wegovy HD Side Effects

The side-effect pattern on 7.2 mg is the familiar GLP-1 one, a few points higher than on 2.4 mg. The one real difference is dysesthesia, which almost quadruples.

  • Nausea: 7.2 mg 39%, 2.4 mg 35%, placebo 13%

  • Vomiting: 7.2 mg 22%, 2.4 mg 16%, placebo 6%

  • Dysesthesia (skin tingling, burning): 7.2 mg 22%, 2.4 mg 6%, placebo 0%

  • Constipation: 7.2 mg 20%, 2.4 mg 19%, placebo 8%

  • Abdominal pain: 7.2 mg 12%, 2.4 mg 9%, placebo 7%

  • Fatigue: 7.2 mg 11%, 2.4 mg 9%, placebo 5%

  • Headache: 7.2 mg 9%, 2.4 mg 8%, placebo 7%

  • Dizziness: 7.2 mg 6%, 2.4 mg 5%, placebo 1%

  • Hair loss: 7.2 mg 6%, 2.4 mg 3%, placebo 1%

  • Stopped for side effects: 7.2 mg 5%, 2.4 mg 5%, placebo 2%

FDA label section 6.1, STEP UP and STEP UP T2D pooled (7.2 mg N=1,311 / 2.4 mg N=304 / placebo N=303). Most stops were for digestive problems: 3% on either Wegovy dose vs 0.3% on placebo.

Dysesthesia is the new one. It means altered skin feeling: tingling, burning, pain or sensitivity of the skin, and the label says it rises with dose. Of 288 people who had it on 7.2 mg, 2% stopped the drug, 8% paused and 23% had the dose lowered; most of them recovered. Of 38 people who went back up to 7.2 mg afterwards, 17 had it again. The thyroid C-cell boxed warning applies to every Wegovy dose.

Related: semaglutide side effects and managing GLP-1 nausea.

06 Competitor

Wegovy HD vs Zepbound

Wegovy HD 7.2 mg

$399/mo

Drug
Semaglutide, weekly
Trial result at 72 weeks
18.8% (STEP UP, label ITT)
Self-pay per month
$399 (NovoCare)
Who starts it
Only after 4+ weeks on 2.4 mg

Zepbound 15 mg

$449/mo

Drug
Tirzepatide, weekly
Trial result at 72 weeks
20.9% (SURMOUNT-1)
Self-pay per month
$449 (LillyDirect, refill within 45 days)
Who starts it
Escalates from 2.5 mg

In September 2026 Lilly published an indirect comparison of SURMOUNT-1 and STEP UP, adjusted for sex, age, baseline weight and A1C. It put Zepbound 15 mg 4.5 points ahead and 10 mg 3.2 points ahead of Wegovy 7.2 mg under the treatment-regimen estimand. Under the efficacy estimand the gaps shrank, and both the 15 mg (1.8 points) and 10 mg (0.7 points) differences were not statistically significant. It is not a head-to-head trial, and Lilly makes Zepbound.

Full breakdown of the Lilly analysis · Zepbound vs Wegovy · Zepbound cost

07 Next steps

How to Get Wegovy HD

  1. 1. Reach 2.4 mg. You need a current Wegovy prescription and at least 4 weeks on 2.4 mg that you tolerate.
  2. 2. See your prescriber. They decide whether more weight reduction is clinically indicated and write the 7.2 mg pen. If you have insurance, ask whether your plan covers the HD strength or needs a new prior authorization.
  3. 3. Fill it. NovoCare Pharmacy ($399 self-pay), a retail pharmacy with your insurance, the Medicare GLP-1 Bridge ($50) if you qualify, or a telehealth clinic.

Ro

Lists Wegovy HD 7.2 mg at $399 plus Body membership; insurance concierge handles prior authorization.

Ro GLP-1 reviews

Hers

Branded Wegovy pen from $199 with "high dose available"; membership $39 first month, then $149/mo.

How much does Hers cost

PlushCare

Writes the Wegovy prescription for your own pharmacy and insurance; $19.99/mo membership, $129 visit without insurance.

PlushCare review

Step-by-step for the standard doses: how to get Wegovy.

Medical Disclaimer

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or qualified health provider with any questions about a medical condition or medication. Never disregard professional medical advice or delay seeking it because of something you have read on this website.

08 FAQ

Wegovy HD FAQ

What is Wegovy HD?
Wegovy HD is a 7.2 mg once-weekly dose of Wegovy (semaglutide) in a single-dose pen. The FDA approved it on March 19, 2026 for adults who have tolerated Wegovy 2.4 mg for at least 4 weeks and need more weight reduction. It is the same drug as regular Wegovy at three times the top standard dose, and it is approved for weight reduction only, not for heart-risk reduction or MASH.
How much does Wegovy HD cost?
NovoCare Pharmacy self-pay is $399 a month for Wegovy HD 7.2 mg, compared with $349 for the 0.25 to 2.4 mg doses, as of Oct 2026 and subject to change. Ro lists the same $399 medication price plus its membership. With commercial insurance that covers Wegovy, the savings card can bring the cost to as little as $25 a month.
How much weight can you lose on Wegovy 7.2 mg?
In the STEP UP trial, adults on 7.2 mg lost an average of 18.8% of body weight at 72 weeks counting everyone randomized, versus 15.5% on 2.4 mg and 3.9% on placebo. Novo Nordisk reports 20.7% for people who stayed on treatment. About 45.5% lost at least 20%. In people with type 2 diabetes the label figure was 13.2%. Individual results vary.
Can I start on Wegovy HD?
No. The label requires the standard escalation first: 0.25 mg, 0.5 mg, 1 mg and 1.7 mg for 4 weeks each, then 2.4 mg. Only patients who tolerate 2.4 mg for at least 4 weeks and need more weight reduction can move to 7.2 mg, so week 21 is the earliest point. Your prescriber sets the dose; 7.2 mg is never a starting dose.
What are Wegovy HD side effects?
Mostly digestive: nausea in 39% and vomiting in 22% of people on 7.2 mg in STEP UP, versus 35% and 16% on 2.4 mg. The new one is dysesthesia, an altered skin feeling such as tingling or burning, reported by 22% on 7.2 mg versus 6% on 2.4 mg. About 5% stopped treatment for side effects on either dose, against 2% on placebo.
Is Wegovy HD better than Zepbound?
There is no head-to-head trial. A Lilly-sponsored indirect comparison of SURMOUNT-1 and STEP UP estimated 4.5 percentage points more weight loss with Zepbound 15 mg and 3.2 points with 10 mg than with Wegovy 7.2 mg; the gap shrank under a second statistical method. On self-pay price, Wegovy HD is $399 and Zepbound 15 mg $449 with refills within 45 days.
Does Medicare cover Wegovy HD?
Yes, through the Medicare GLP-1 Bridge, which runs Jul 1, 2026 to Dec 31, 2027 with a $50 monthly copay for eligible Part D enrollees. CMS says all Wegovy formulations are included and lists the HD pen's NDC, 0169-4572-14. Eligibility depends on BMI and weight-related conditions, and people already covered for a GLP-1 under Part D are excluded.

Already on Wegovy 2.4 mg?

Ask a prescriber whether 7.2 mg fits. Self-pay is $399 a month at NovoCare as of Oct 2026.

Dosing, trial data and side effects from the Wegovy label (Rev. 06/2026); prices from NovoCare, Oct 2026.
Updated
How we check facts →

Last updated Oct 29, 2026. Prices checked on NovoCare, Ro and CMS in Oct 2026; dosing and trial data from the Wegovy prescribing information, Rev. 06/2026.